May Han
Partner at Cure Ventures
About
A drug discovery and development expert with over 20 years of experience in program management and scientific leadership across multiple modalities. Brings deep understanding of oncology and metabolic diseases, with experience managing large portfolios of clinical-stage programs at companies including Novartis, AVEO, and Millennium Pharmaceuticals.
Colleagues at Cure Ventures
Albert J. Robichaud
Partner at Cure Ventures
Annie Mitsak
Partner at Cure Ventures
Courtney Turner
Director of Finance at Cure Ventures
David Fallace
Managing Partner at Cure Ventures
Dr. Michael Aberman
Investor at Cure Ventures
Dr. Milenko Cicmil
Investor at Cure Ventures
Drew King
CFO and Partner at Cure Ventures
Jeffrey M. Jonas
Partner at Cure Ventures